Closing Bell: Hls Therapeutics Inc up on Friday (HLS)

In today's trading, Hls Therapeutics Inc shares opened at $3.02 and closed at $3.15. prices ranged from a low of $3.02 to a high of $3.15.

The price advanced 0.32% from the previous day's close of $3.14.

Today across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.84% at 5346.56, the Dow Jones Industrial Average closed -1.51% at 39737.26 and the Nasdaq Composite closed -2.43% at 16776.16.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

Trading volume was 345 on 4 total trades. On average, Hls Therapeutics Inc has traded 969 shares over 5 days and 10,639 year-to-date.

The TSX overall saw 432 price advancers against 4,843 declines and 43 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $6.00 (August 03,2023) and low as $3.02 (August 02,2024). Moreover, the shares have shrunken -47.50% in the last 12 months, while in 2024, they have shrunken -20.25%.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $100.22 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Based on 5.00 analysts, Hls Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..